Pathway to Cures, the venture philanthropy fund of the National Bleeding Disorders Foundation (NBDF), presented their annual fund update at the NBDF Research Round Table in Washington, DC last month.

Analyze the CGDV ETF: strategy vs. “dividend value” label, returns vs. SPY, earnings growth, valuation risk, overlap, and low ...